Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu (Q33447149)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu |
scientific article |
Statements
1 reference
Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu (English)
1 reference
Patrick Schöffski
1 reference
Stefan Sleijfer
1 reference
Jaap Verweij
1 reference
Zsuzsa Papai
1 reference
Sandrine Marreaud
1 reference
Martine van Glabbeke
1 reference
Michelle Scurr
1 reference
Françoise Collin
1 reference
Lini Pandite
1 reference
Annick De Brauwer
1 reference
18 May 2009
1 reference
1 reference
27
1 reference
19
1 reference
3126-3132
1 reference
Identifiers
1 reference
1 reference